Endometrial progesterone and estrogen receptors and bleeding disturbances in depot medroxyprogesterone acetate users
BACKGROUND: Depot medroxyprogesterone acetate (DMPA) is a very popular hormonal contraceptive. Unpredictable bleeding disturbances are the main reasons for discontinuation and may be mediated through endometrial hormone receptors. This study was aimed to compare the expression of progesterone and es...
Saved in:
Published in | Human reproduction (Oxford) Vol. 19; no. 3; pp. 547 - 552 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Oxford University Press
01.03.2004
Oxford Publishing Limited (England) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | BACKGROUND: Depot medroxyprogesterone acetate (DMPA) is a very popular hormonal contraceptive. Unpredictable bleeding disturbances are the main reasons for discontinuation and may be mediated through endometrial hormone receptors. This study was aimed to compare the expression of progesterone and estrogen receptors in the endometrium of bleeding DMPA users with that of amenorrhoeic DMPA users. METHODS: Subjects were recruited between April 2000 and January 2001. On the day of the third DMPA injection, 42 amenorrhoeic DMPA users and 42 DMPA users who had frequent or prolonged endometrial bleeding and were bleeding on that day were matched by age and body mass index. Endometrial biopsies were collected for immunohistochemical study of progesterone receptor A plus B (PRAB) and B alone (PRB) and estrogen receptor α (ERα) and β (ERβ) expression. RESULTS: There were 23 adequate endometrial samples from each group. There were no differences in any of a series of comparisons of PRAB, PRB, ERα and ERβ expression in glands or stroma between the groups. Serum estradiol and progesterone levels were also not different between the groups. CONCLUSIONS: Endometrial PRAB, PRB, ERα and ERβ expression in glands and stroma was not different between DMPA users who had frequent or prolonged bleeding and amenorrhoeic DMPA users. |
---|---|
Bibliography: | ark:/67375/HXZ-QVMX3LH7-C istex:778D9736BC310F1B2661619AE6A7893C19F4B076 4To whom correspondence should be addressed at: Department of Obstetrics and Gynaecology, Faculty of Medicine, Chulalongkorn University, Rama IV Road, Bangkok 10330, Thailand. e‐mail: trcwsr@md2.md.chula.ac.th local:deh123 |
ISSN: | 0268-1161 1460-2350 1460-2350 |
DOI: | 10.1093/humrep/deh123 |